ARCH Motorcycle partners with Hexagon to craft bespoke high-performance cruisers with production motorcycle quality

NORTH KINGSTOWN, R.I., March 14, 2024 /PRNewswire/ — Hexagon’s Manufacturing Intelligence division and ARCH Motorcycle, a manufacturer of high-performance bespoke motorcycles, have partnered to support the quality control demands of engineering and producing unique riding experiences for ARCH customers. Continue Reading Aluminum part of an ARCH motorcycle is inspected with a Hexagon portable measuring arm The ARCH 1s By combining… Continue reading ARCH Motorcycle partners with Hexagon to craft bespoke high-performance cruisers with production motorcycle quality

FOR THE FIRST TIME IN NEARLY A YEAR, GLOBAL SUPPLY CHAINS ARE CLOSE TO FULL CAPACITY, SIGNALING RECOVERY IN MANUFACTURING IN FEBRUARY: GEP GLOBAL SUPPLY CHAIN VOLATILITY INDEX

Input demand beginning to recover across all major markets, after a protracted nearly two-year period of decline North American suppliers see capacity stretched for the first time in nearly a year as manufacturers, especially in consumer-facing sectors, report growth Global transportation costs fall despite Red Sea disruptions CLARK, N.J., March 14, 2024 /PRNewswire/ — The… Continue reading FOR THE FIRST TIME IN NEARLY A YEAR, GLOBAL SUPPLY CHAINS ARE CLOSE TO FULL CAPACITY, SIGNALING RECOVERY IN MANUFACTURING IN FEBRUARY: GEP GLOBAL SUPPLY CHAIN VOLATILITY INDEX

Demystifying Satellite Data Transmission: A Deep Dive into YTTEK’s Y.FORCE S Modem Capabilities

WASHINGTON, March 17, 2024 /PRNewswire/ — In a significant advancement within the field of satellite communication technology, YTTEK is pleased to introduce the new product “Y.FORCE S” satellite modem. This ground station signal analysis and reception device, accompanied by Recorder and Real-Time Analysis products, heralds to in decoding and capturing X-Band space signals, delivering unparalleled… Continue reading Demystifying Satellite Data Transmission: A Deep Dive into YTTEK’s Y.FORCE S Modem Capabilities

India Baby Care Products Market size to grow by USD 15.69 billion from 2022 to 2027, Market is fragmented due to the presence of prominent companies like Abbott Laboratories, Artsana Spa, Bio Veda Action Research Co., and many more

NEW YORK, March 17, 2024 /PRNewswire/ — The India – Baby Care Products Market is estimated to grow by USD 15.69 billion, accelerating at a CAGR of 17.31%, during the forecast period. The baby care products market in India is fragmented owing to the presence of many global and regional companies. A few prominent companies that offer baby… Continue reading India Baby Care Products Market size to grow by USD 15.69 billion from 2022 to 2027, Market is fragmented due to the presence of prominent companies like Abbott Laboratories, Artsana Spa, Bio Veda Action Research Co., and many more

Everest Medicines Strengthens Management Team with Appointments of Chief Medical Officer and Chief Product Officer

SHANGHAI, March 17, 2024 /PRNewswire/ — Everest Medicines (HKEX: 1952.HK, “Everest,” or the “Company”), a biopharmaceutical company focused on the discovery, development, manufacturing and commercialization of innovative medicines and vaccines, today announced that the company has strengthened its management team with the appointments of Ms. Sandra Zeng as Chief Medical Officer and Mr. Rico Liang… Continue reading Everest Medicines Strengthens Management Team with Appointments of Chief Medical Officer and Chief Product Officer

ZYMFENTRA™(infliximab-dyyb), the first and only FDA-approved subcutaneous infliximab, now commercially available in the U.S.

ZYMFENTRA™ is the first FDA-approved subcutaneous infliximab for the treatment of moderately to severely active ulcerative colitis and moderately to severely active Crohn’s disease ZYMFENTRA™ is commercially available across the U.S. on March 15, 2024 JERSEY CITY, N.J., March 17, 2024 /PRNewswire/ — Celltrion USA announced today the availability of a ZYMFENTRA™ (infliximab-dyyb), a subcutaneous (SC)… Continue reading ZYMFENTRA™(infliximab-dyyb), the first and only FDA-approved subcutaneous infliximab, now commercially available in the U.S.

Mediwave remporte une reconnaissance mondiale aux GLOMO Awards 2024 pour ses technologies de la santé à destination des interventions d’urgence

SINGAPOUR, 18 mars 2024 /PRNewswire/ — Mediwave, une entreprise de pointe dans le domaine des technologies de la santé, a été reconnue comme finaliste lors des prestigieux Global Mobile Awards (GLOMO), dans le cadre du Mobile World Congress (MWC) organisé par la GSMA à Barcelone, en Espagne. Cette reconnaissance souligne les contributions exceptionnelles de Mediwave… Continue reading Mediwave remporte une reconnaissance mondiale aux GLOMO Awards 2024 pour ses technologies de la santé à destination des interventions d’urgence

Mediwave obtiene reconocimiento global en los premios GLOMO 2024 por Emergency Response HealthTech

SINGAPUR, 18 de marzo de 2024 /PRNewswire/ — Mediwave, una empresa de tecnología sanitaria de vanguardia, fue reconocida como finalista en los prestigiosos Global Mobile Awards (GLOMO), parte del Mobile World Congress (MWC) impulsado por GSMA en Barcelona, España. Este reconocimiento subraya las contribuciones excepcionales de Mediwave al campo, en particular su uso innovador e… Continue reading Mediwave obtiene reconocimiento global en los premios GLOMO 2024 por Emergency Response HealthTech

Mediwave Earns Global Recognition at GLOMO Awards 2024 for Emergency Response HealthTech

SINGAPORE, March 18, 2024 /PRNewswire/ — Mediwave, a leading-edge HealthTech company, was recognised as a finalist at the prestigious Global Mobile Awards (GLOMO), part of the Mobile World Congress (MWC) powered by GSMA in Barcelona, Spain. This acknowledgment underscores Mediwave’s exceptional contributions to the field, particularly its innovative and integrated use of AI, Internet of… Continue reading Mediwave Earns Global Recognition at GLOMO Awards 2024 for Emergency Response HealthTech

Fair Market Value Capital Partners and TD Asset Management jointly acquire a minority interest in PSA Italy from PSA International

PSA Italy operates three container terminals in the Port of Genoa and Port of Venice that are the premier gateway terminals serving the Northern Italian hinterland, handling a total of two million TEUs in 2023. Through its investment in PSA Italy, FMV and TDGIF will continue to support PSA Italy’s strategy to grow both within… Continue reading Fair Market Value Capital Partners and TD Asset Management jointly acquire a minority interest in PSA Italy from PSA International